Linda Garland, MD

Professor, Medicine, Clinical Scholar
lgarland@uacc.arizona.edu

Undergraduate Education

University of Texas at Austin Austin, Texas, Bachelor of Arts with High Honors, 1983, Special Honors in Psychology 
1979 -1983                            

Medical Education  

University of Texas Health Science Center at San Antonio, San Antonio, Texas 
8/1984 -5/1988                

Surgery Internship, Department of Surgery University of Texas Health Science Center at San Antonio, San Antonio, Texas 
7/1988 -6/1989                    

Internal Medicine Internship and Residency, Department of Internal Medicine, University of South Florida College of Medicine, Tampa, Florida              
7/1990 - 6/1993                                                   

Medical Oncology and Hematology Fellowship, Division of Medical Oncology and Hematology, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida 
7/1993 – 6/1996                       

Employment 

7/1996 – 1/2000                            

Assistant Professor of Medicine, Thoracic Oncology Program, H. Lee Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, Florida 

2/2000 – 6/2007                            

Assistant Professor of Medicine, Clinical Scholar Track,

Director, Clinical Research in Thoracic Oncology, University of Arizona Cancer Center, Division of Hematology/Oncology, Department of Medicine 

 7/2007 – 5/2018                            

Associate Professor of Medicine, Clinical Scholar Track 

Director, Clinical Research in Thoracic Oncology, University of Arizona Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of Arizona Health Sciences Center 

6/2018 – Present                    

Professor of Medicine, Clinical Scholar Track 

Director, Clinical Research in Thoracic Oncology 

University of Arizona Cancer Center, Division of Hematology/Oncology, Department of Medicine , University of Arizona Health Sciences Center 

Cancer Focus

-Lung cancer chemoprevention with repurposed drugs including arachidonic acid inhibitors and immune modulators, and incorporating novel non-invasive biomarkers of gene expression. 

-Lung cancer survivorship studies including lung cancer stigma, lung cancer outcomes by race/ethnicity, coping responses in the face of the COVID pandemic, tobacco cessation.

-Translation of a novel methylation signature discovered at the UACC for improving lung cancer diagnosis and treatment response. 

Research Program Role
Cancer Prevention and Control Program

Display Name
Linda Garland, MD

Publications

Garland LL, Guillen-Rodriguez J, Hsu C-H, Yozwiak M, Zhang HH, Alberts DS, Davis LE, Szabo E, Merenstein C, Lel J, et al. 2019. Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial. Cancer Prev Res (Phila). 12:809–820. doi:10.1158/1940-6207.CAPR-19-0036.